Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 14, 2017 Filed Dec 15, 2017 23:00 UTC |
GRIECO WILLIAMDirector
|
Tax withholdingCommon Stock | 1,732 | $32.78 | $56,774.96 |
DisclosureSEC source: 0000899243-17-028875 · doc4.xml · nonDerivative · entry 2 GRIECO WILLIAM · CIK 0001248557 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,281 Read SEC document |
| December 14, 2017 Filed Dec 15, 2017 23:00 UTC |
GRIECO WILLIAMDirector
|
Exercise / conversionCommon Stock | 5,000 | $11.36 | $56,800.00 |
DisclosureSEC source: 0000899243-17-028875 · doc4.xml · nonDerivative · entry 1 GRIECO WILLIAM · CIK 0001248557 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2017 Filed Feb 7, 2018 18:01 UTC |
Howard Christopher LEVP, GC and Secretary
|
GiftCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-003118 · doc5.xml · nonDerivative · entry 4 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 120,000 F2 · kind: On December 4, 2017, the reporting person contributed 60,000 shares of common stock to the Christopher L. Howard Family 2017 Grantor Retained Annuity Trust for the benefit of himself and his children. The reporting person's spouse is trustee of the trust. F3 · ownership.nature: By the Christopher L. Howard Family 2017 Grantor Retained Annuity Trust and the Angie Parrott Howard Family 2017 Grantor Retained Annuity Trust. Includes 60,000 shares previously held by Angie Howard that were distributed to the Angie Parrott Howard Family 2017 Grantor Retained Annuity Trust. The reporting person is trustee of the Angie Parrott Howard Family 2017 Grantor Retained Annuity Trust. Read SEC document |
| December 04, 2017 Filed Feb 7, 2018 18:01 UTC |
Howard Christopher LEVP, GC and Secretary
|
GiftCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-003118 · doc5.xml · nonDerivative · entry 3 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,286 F2 · kind: On December 4, 2017, the reporting person contributed 60,000 shares of common stock to the Christopher L. Howard Family 2017 Grantor Retained Annuity Trust for the benefit of himself and his children. The reporting person's spouse is trustee of the trust. Read SEC document |
| November 09, 2017 Filed Feb 7, 2018 18:01 UTC |
Howard Christopher LEVP, GC and Secretary
|
GiftCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-003118 · doc5.xml · nonDerivative · entry 2 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 60,000 F1 · kind: This transaction involved a gift of securities by the reporting person to his spouse, Angie Howard. Read SEC document |
| November 09, 2017 Filed Feb 7, 2018 18:01 UTC |
Howard Christopher LEVP, GC and Secretary
|
GiftCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-003118 · doc5.xml · nonDerivative · entry 1 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,286 F1 · kind: This transaction involved a gift of securities by the reporting person to his spouse, Angie Howard. Read SEC document |
| August 22, 2017 Filed Aug 22, 2017 18:11 UTC |
Fincher Ronald MorganChief Operating Officer
|
SaleCommon Stock | 30,000 | $50.69 | $1,520,700.00 |
DisclosureSEC source: 0000899243-17-020876 · doc4.xml · nonDerivative · entry 2 Fincher Ronald Morgan · CIK 0001448040 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 11,135 F1 · balance_after: Mr. Fincher expressly disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein. F2 · ownership.nature: By the Ras W. Fincher II Trust u/a/d 09/13/2011, the Morgan M. Fincher Trust u/a/d 09/13/2011 and the Cody C. Fincher Trust u/a/d 09/13/2011. Read SEC document |
| August 22, 2017 Filed Aug 22, 2017 18:11 UTC |
Fincher Ronald MorganChief Operating Officer
|
SaleCommon Stock | 50,000 | $50.69 | $2,534,500.00 |
DisclosureSEC source: 0000899243-17-020876 · doc4.xml · nonDerivative · entry 1 Fincher Ronald Morgan · CIK 0001448040 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,071 Read SEC document |
| August 22, 2017 Filed Aug 22, 2017 22:40 UTC |
WAUD REEVE BDirector
|
SaleCommon Stock, par value $0.01 per share | 984,075 | $50.69 | $49,882,761.75 |
DisclosureSEC source: 0000899243-17-020885 · doc4.xml · nonDerivative · entry 1 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,197,606 F1 · shares: Represents shares sold in an underwritten offering as follows: (i) 193,745 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 354,195 shares by Waud Capital Partners QP II, L.P. ("WCP QP II"), (iii) 54,057 shares by WCP FIF II (Acadia), L.P. ("WCP FIF II") (iv) 31,097 shares by Waud Capital Partners III, L.P. ("WCP III"), (v) 175,851 shares by Waud Capital Partners QP III, L.P. ("WCP QP III"), (vi) 77,176 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III") (vii) 55,363 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II") (viii) 28,412 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III") and (ix) 14,179 shares by Waud Family Partners, L.P. ("WFP LP"). F2 · balance_after: The shares are owned of record as follows: (i) 331,113 shares by the Halcyon Exempt Family Trust (the "Halcyon Trust"), (ii) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (iii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC") and (iv) 795,667 shares by Crystal Cove LP. F3 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the Manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F4 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F5 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| August 22, 2017 Filed Aug 22, 2017 18:13 UTC |
JACOBS JOEY ADirector · Chief Executive Officer
|
SaleCommon Stock | 300,000 | $50.69 | $15,207,000.00 |
DisclosureSEC source: 0000899243-17-020878 · doc4.xml · nonDerivative · entry 2 JACOBS JOEY A · CIK 0001243878 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 267,649 F1 · balance_after: Mr. Jacobs expressly disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein. F2 · ownership.nature: By the Jeremy Brent Jacobs GST Non-Exempt u/a/d 04/26/2011 and Scott Douglas Jacobs GST Non-Exempt Trust u/a/d 04/26/2011. Read SEC document |
| August 22, 2017 Filed Aug 22, 2017 18:13 UTC |
JACOBS JOEY ADirector · Chief Executive Officer
|
SaleCommon Stock | 200,000 | $50.69 | $10,138,000.00 |
DisclosureSEC source: 0000899243-17-020878 · doc4.xml · nonDerivative · entry 1 JACOBS JOEY A · CIK 0001243878 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,496 Read SEC document |
| August 22, 2017 Filed Aug 22, 2017 18:05 UTC |
TURNER BRENTPresident
|
SaleCommon Stock | 206,252 | $50.69 | $10,454,913.88 |
DisclosureSEC source: 0000899243-17-020872 · doc4.xml · nonDerivative · entry 2 TURNER BRENT · CIK 0001243882 · President 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · ownership.nature: By the Elizabeth Grace Turner 2011 Vested Trust and the William Jesse Turner 2011 Vested Trust. Read SEC document |
| August 22, 2017 Filed Aug 22, 2017 18:07 UTC |
Howard Christopher LEVP, GC and Secretary
|
SaleCommon Stock | 53,713 | $50.69 | $2,722,711.97 |
DisclosureSEC source: 0000899243-17-020874 · doc4.xml · nonDerivative · entry 1 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,286 Read SEC document |
| August 22, 2017 Filed Aug 24, 2017 17:44 UTC |
Gordon Christopher RDirector
|
SaleCommon Stock, par value $0.01 | 998,438 | $50.69 | $50,610,822.22 |
DisclosureSEC source: 0000899243-17-020976 · doc4.xml · nonDerivative · entry 1 Gordon Christopher R · CIK 0001432313 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 F1 · ownership.nature: Represents shares of Common Stock held directly by Bain Capital Fund VIII, LLC, Bain Capital VIII Coinvestment Fund, LLC, Bain Capital (CR), L.P., BCIP Associates III, LLC, BCIP Associates III-B, LLC, BCIP T Associates III, LLC, BCIP T Associates III-B, LLC, and BCIP Associates-G (collectively, the "Bain Capital Entities"). F2 · ownership.nature: The governance, investment strategy and decision-making process with respect to investments held by the Bain Capital Entities is directed by the Global Private Equity Board of Bain Capital Investors, LLC ("BCI"). Christopher Gordon is a Managing Director of BCI. By virtue of the relationships described in these footnotes, Mr. Gordon may be deemed to share voting and dispositive power with respect to the shares of Common Stock held by the Bain Capital Entities. Mr. Gordon disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| August 11, 2017 Filed Aug 14, 2017 23:01 UTC |
GRIECO WILLIAMDirector
|
SaleCommon Stock | 1,000 | $51.75 | $51,745.00 |
DisclosureSEC source: 0000899243-17-020253 · doc4.xml · nonDerivative · entry 2 GRIECO WILLIAM · CIK 0001248557 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,013 Read SEC document |
| August 11, 2017 Filed Aug 14, 2017 23:01 UTC |
GRIECO WILLIAMDirector
|
SaleCommon Stock | 1,000 | $51.68 | $51,675.00 |
DisclosureSEC source: 0000899243-17-020253 · doc4.xml · nonDerivative · entry 1 GRIECO WILLIAM · CIK 0001248557 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,013 Read SEC document |
| August 03, 2017 Filed Aug 4, 2017 17:01 UTC |
Howard Christopher LEVP, GC and Secretary
|
SaleCommon Stock | 16,762 | $52.47 | $879,559.13 |
DisclosureSEC source: 0000899243-17-019782 · doc4.xml · nonDerivative · entry 1 Howard Christopher L · CIK 0001337573 · EVP, GC and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,999 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.38 to $52.59, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 31, 2017 Filed Aug 1, 2017 22:14 UTC |
WAUD REEVE BDirector
|
SaleCommon Stock, par value $0.01 per share | 1,190,000 | $51.65 | $61,463,500.00 |
DisclosureSEC source: 0000899243-17-019440 · doc4.xml · nonDerivative · entry 3 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 2,181,681 F4 · shares: Represents shares sold under Rule 144 as follows: (i) 234,287 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 428,316 shares by Waud Capital Partners QP II, L.P. ("WCP QP II"), (iii) 65,368 shares by WCP FIF II (Acadia), L.P. ("WCP FIF II") (iv) 37,604 shares by Waud Capital Partners III, L.P. ("WCP III"), (v) 212,649 shares by Waud Capital Partners QP III, L.P. ("WCP QP III"), (vi) 93,325 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III") (vii) 66,948 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II") (viii) 34,358 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III") and (ix) 17,145 shares by Waud Family Partners, L.P. ("WFP LP"). F5 · balance_after: The shares are owned of record as follows: (i) 193,745 shares by WCP II, (ii) 354,195 shares by WCP QP II, (iii) 54,057 by WCP FIF II, (iv) 31,097 shares by WCP III, (v) 175,851 shares by WCP QP III, (vi) 77,176 shares by WCP FIF III, (vii) 55,363 shares by Waud Affiliates II, (viii) 28,412 shares by Waud Affiliates III, (ix) 331,113 shares by the Halcyon Trust, (x) 14,179 shares by WFP LP, (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC") and (xiii) 795,667 shares by Crystal Cove LP. F6 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the Manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F7 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F8 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 16:06 UTC |
Gordon Christopher RDirector
|
SaleCommon Stock, par value $0.01 | 2,453,764 | $51.65 | $126,736,910.60 |
DisclosureSEC source: 0000899243-17-019535 · doc4.xml · nonDerivative · entry 1 Gordon Christopher R · CIK 0001432313 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 998,438 F1 · ownership.nature: Represents shares of Common Stock held directly by Bain Capital Fund VIII, LLC, Bain Capital VIII Coinvestment Fund, LLC, Bain Capital (CR), L.P., BCIP Associates III, LLC, BCIP Associates III-B, LLC, BCIP T Associates III, LLC, BCIP T Associates III-B, LLC, and BCIP Associates-G (collectively, the "Bain Capital Entities"). F2 · ownership.nature: The governance, investment strategy and decision-making process with respect to investments held by the Bain Capital Entities is directed by the Global Private Equity Board of Bain Capital Investors, LLC ("BCI"). Christopher Gordon is a Managing Director of BCI. By virtue of the relationships described in these footnotes, Mr. Gordon may be deemed to share voting and dispositive power with respect to all of the shares of Common Stock held by the Bain Capital Entities. Mr. Gordon disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 22:01 UTC |
Schwieger ScottChief Compliance Officer
|
Exercise / conversionCommon Stock · Derivative | 1,000 | $0.00 Strike: $29.39 | $0.00 |
DisclosureSEC source: 0000899243-17-019588 · doc4.xml · derivative · entry 7 Schwieger Scott · CIK 0001697431 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2023-03-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 22:01 UTC |
Schwieger ScottChief Compliance Officer
|
Exercise / conversionCommon Stock · Derivative | 1,350 | $0.00 Strike: $50.75 | $0.00 |
DisclosureSEC source: 0000899243-17-019588 · doc4.xml · derivative · entry 6 Schwieger Scott · CIK 0001697431 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450 Underlying: Common Stock · 1,350 shares Expires 2024-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 22:01 UTC |
Schwieger ScottChief Compliance Officer
|
SaleCommon Stock | 541 | $52.91 | $28,624.63 |
DisclosureSEC source: 0000899243-17-019588 · doc4.xml · nonDerivative · entry 5 Schwieger Scott · CIK 0001697431 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,950 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 22:01 UTC |
Schwieger ScottChief Compliance Officer
|
SaleCommon Stock | 1,000 | $52.84 | $52,836.50 |
DisclosureSEC source: 0000899243-17-019588 · doc4.xml · nonDerivative · entry 4 Schwieger Scott · CIK 0001697431 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,491 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 22:01 UTC |
Schwieger ScottChief Compliance Officer
|
SaleCommon Stock | 1,350 | $52.84 | $71,330.22 |
DisclosureSEC source: 0000899243-17-019588 · doc4.xml · nonDerivative · entry 3 Schwieger Scott · CIK 0001697431 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,491 Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 22:01 UTC |
Schwieger ScottChief Compliance Officer
|
Exercise / conversionCommon Stock | 1,000 | $29.39 | $29,390.00 |
DisclosureSEC source: 0000899243-17-019588 · doc4.xml · nonDerivative · entry 2 Schwieger Scott · CIK 0001697431 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,841 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 22:01 UTC |
Schwieger ScottChief Compliance Officer
|
Exercise / conversionCommon Stock | 1,350 | $50.75 | $68,512.50 |
DisclosureSEC source: 0000899243-17-019588 · doc4.xml · nonDerivative · entry 1 Schwieger Scott · CIK 0001697431 · Chief Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,841 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2017 Filed Aug 1, 2017 22:14 UTC |
WAUD REEVE BDirector
|
SaleCommon Stock, par value $0.01 per share | 15,400 | $53.63 | $825,902.00 |
DisclosureSEC source: 0000899243-17-019440 · doc4.xml · nonDerivative · entry 2 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,371,681 F1 · shares: Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the "Halcyon Trust") on March 17, 2017. F3 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $53.50 to $53.82, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F6 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the Manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F7 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F8 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 28, 2017 Filed Aug 1, 2017 22:14 UTC |
WAUD REEVE BDirector
|
SaleCommon Stock, par value $0.01 per share | 34,600 | $53.13 | $1,838,298.00 |
DisclosureSEC source: 0000899243-17-019440 · doc4.xml · nonDerivative · entry 1 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,387,081 F1 · shares: Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the "Halcyon Trust") on March 17, 2017. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $52.50 to $53.49, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F6 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the Manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F7 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F8 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| July 05, 2017 Filed Jul 6, 2017 21:53 UTC |
WAUD REEVE BDirector
|
SaleCommon Stock, par value $0.01 per share | 50,000 | $50.04 | $2,502,150.00 |
DisclosureSEC source: 0000899243-17-018000 · doc4.xml · nonDerivative · entry 1 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,421,681 F1 · shares: Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the "Halcyon Trust") on March 17, 2017. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $50.00 to $50.17, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3 · balance_after: The shares are owned of record as follows: (i) 428,032 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 782,511 shares by Waud Capital Partners QP II, L.P. ("WCP QP II"), (iii) 119,425 by WCP FIF II (Acadia), L.P. ("WCP FIF II"), (iv) 122,311 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II"), (v) 62,770 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III"), (vi) 170,501 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III"), (vii) 388,500 shares by Waud Capital Partners QP III, L.P. ("WCP QP III"), (viii) 68,701 shares by Waud Capital Partners III, L.P. ("WCP III"), (ix) 381,113 shares by the Halcyon Trust, (x) 31,324 shares by Waud Family Partners, L.P. ("WFP LP"), (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 37,493 shares by WCP LLC and (xiii) 795,667 shares by Crystal Cove LP. F4 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the Manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F5 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F6 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 22, 2017 Filed Jun 23, 2017 20:10 UTC |
WAUD REEVE BDirector
|
SaleCommon Stock, par value $0.01 per share | 50,000 | $47.51 | $2,375,600.00 |
DisclosureSEC source: 0000899243-17-017080 · doc4.xml · nonDerivative · entry 1 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,471,681 F1 · shares: Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family Trust (the "Halcyon Trust") on March 17, 2017. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $47.50 to $47.57, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3 · balance_after: The shares are owned of record as follows: (i) 428,032 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 782,511 shares by Waud Capital Partners QP II, L.P. ("WCP QP II"), (iii) 119,425 by WCP FIF II (Acadia), L.P. ("WCP FIF II"), (iv) 122,311 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II"), (v) 62,770 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III"), (vi) 170,501 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III"), (vii) 388,500 shares by Waud Capital Partners QP III, L.P. ("WCP QP III"), (viii) 68,701 shares by Waud Capital Partners III, L.P. ("WCP III"), (ix) 431,113 shares by the Halcyon Trust, (x) 31,324 shares by Waud Family Partners, L.P. ("WFP LP"), (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 37,493 shares by WCP LLC and (xiii) 795,667 shares by Crystal Cove LP. F4 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the Manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F5 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F6 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 16, 2017 Filed Jun 19, 2017 22:00 UTC |
GRIECO WILLIAMDirector
|
SaleCommon Stock | 1,000 | $45.41 | $45,406.80 |
DisclosureSEC source: 0000899243-17-016698 · doc4.xml · nonDerivative · entry 2 GRIECO WILLIAM · CIK 0001248557 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,013 Read SEC document |
| June 16, 2017 Filed Jun 19, 2017 22:00 UTC |
GRIECO WILLIAMDirector
|
SaleCommon Stock | 1,000 | $45.44 | $45,436.40 |
DisclosureSEC source: 0000899243-17-016698 · doc4.xml · nonDerivative · entry 1 GRIECO WILLIAM · CIK 0001248557 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,013 Read SEC document |
| June 14, 2017 Filed Jun 15, 2017 20:14 UTC |
WAUD REEVE BDirector
|
SaleCommon Stock, par value $0.01 per share | 724,694 | $45.53 | $32,995,317.82 |
DisclosureSEC source: 0000899243-17-016459 · doc4.xml · nonDerivative · entry 1 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,521,681 F1 · shares: Represents shares sold under Rule 144 as follows: (i) 142,678 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 260,837 shares by Waud Capital Partners QP II, L.P. ("Waud QP II"), (iii) 39,808 shares by WCP FIF II (Acadia), L.P. ("WCP FIF II") (iv) 22,901 shares by Waud Capital Partners III, L.P. ("WCP III"), (v) 129,500 shares by Waud Capital Partners QP III, L.P. ("Waud QP III"), (vi) 56,834 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III") (vii) 40,771 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II") (viii) 20,924 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III") and (ix) 10,441 shares by Waud Family Partners, L.P. ("WFP LP"). F2 · balance_after: The shares are owned of record as follows: (i) 428,032 shares by WCP II, (ii) 782,511 shares by WCP QP II, (iii) 119,425 by WCP FIF II, (iv) 68,701 shares by WCP III, (v) 388,500 shares by WCP QP III, (v) 170,501 shares by WCP FIF III, (vi) 122,311 shares by Waud Affiliates II, (vii) 62,770 shares by Waud Affiliates III, (viii) 481,113 shares by the Halcyon Trust, (ix) 31,324 shares by WFP LP, (x) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xi) 37,493 shares by Waud Capital Partners, L.L.C. ("WCP LLC") and (xii) 795,667 shares by Crystal Cove LP. F3 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the Manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F4 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F5 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| June 09, 2017 Filed Jun 13, 2017 10:06 UTC |
WAUD REEVE BDirector
|
SaleCommon Stock, par value $0.01 per share | 50,000 | $45.09 | $2,254,350.00 |
DisclosureSEC source: 0000899243-17-016149 · doc4.xml · nonDerivative · entry 1 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 4,246,375 F1 · shares: Represents shares sold pursuant to a Rule 10b-5 plan adopted by the Halcyon Exempt Family (the "Halcyon Trust") on March 17, 2017. F2 · price: The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions under Rule 144 at prices ranging from $45.00 to $45.25, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc., any security holder of Acadia Healthcare Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3 · balance_after: The shares are owned of record as follows: (i) 570,710 shares by Waud Capital Partners II, L.P. ("WCP II"), (ii) 1,043,348 shares by Waud Capital Partners QP II, L.P. ("WCP QP II"), (iii) 159,233 by WCP FIF II (Acadia), L.P. ("WCP FIF II"), (iv) 163,082 shares by Waud Capital Affiliates II, L.L.C. ("Waud Affiliates II"), (v) 83,694 shares by Waud Capital Affiliates III, L.L.C. ("Waud Affiliates III"), (vi) 227,335 shares by WCP FIF III (Acadia), L.P. ("WCP FIF III"), (vii) 518,000 shares by Waud Capital Partners QP III, L.P. ("WCP QP III"), (viii) 91,602 shares by Waud Capital Partners III, L.P. ("WCP III"), (ix) 481,113 shares by the Halcyon Trust, (x) 41,765 shares by Waud Family Partners, L.P. ("WFP LP"), (xi) 33,333 shares by Melissa W. Waud, Mr. Waud's wife, (xii) 37,493 shares by WCP LLC and (xiii) 795,667 shares by Crystal Cove LP. F4 · ownership.nature: Waud Capital Partners Management II, L.P. ("WCPM II") is the general partner of WCP II, WCP QP II and WCP FIF II and the manager of Waud Affiliates II. Waud Capital Partners II, L.L.C. ("WCP II LLC") is the general partner of WCPM II. Waud Capital Partners Management III, L.P. ("WCPM III") is the general partner of WCP FIF III, WCP QP III and WCP III and the Manager of Waud Affiliates III. Waud Capital Partners III, L.L.C. ("WCP III LLC") is the general partner of WCPM III. F5 · ownership.nature: Mr. Waud may be deemed to beneficially own the shares of common stock reported herein by virtue of (A) his making decisions for the Limited Partner Committee of each of WCPM II and WCPM III, (B) his being the manager of WCP II LLC and WCP III LLC, (C) his being the general partner of WFP LP, (D) his being the investment advisor of the Halcyon Trust of which Mr. Waud's children are beneficiaries, (E) his being married to Ms. Waud, (F) his being the sole manager of WCP LLC and (G) his being the general partner of Crystal Cove LP. F6 · ownership.nature: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. Read SEC document |
| May 25, 2017 Filed May 26, 2017 16:23 UTC |
Gordon Christopher RDirector
|
GrantCommon Stock, par value $0.01 | 3,752 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-014549 · doc4.xml · nonDerivative · entry 1 Gordon Christopher R · CIK 0001432313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,203 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 25, 2018. Read SEC document |
| May 25, 2017 Filed May 26, 2017 21:00 UTC |
WAUD REEVE BDirector
|
GrantCommon Stock, par value $0.01 per share | 3,752 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-014565 · doc4.xml · nonDerivative · entry 1 WAUD REEVE B · CIK 0001421620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,110 F1 · shares: The shares are held of record by Mr. Reeve B. Waud for the benefit of Waud Capital Partners, L.L.C. ("WCP LLC"), of which Mr. Waud is the sole manager. The shares will vest in three equal annual installments beginning May 25, 2018. F2 · balance_after: Mr. Waud expressly disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. F3 · balance_after: Represents shares held of record for the benefit of WCP LLC. Read SEC document |
| May 25, 2017 Filed May 26, 2017 21:02 UTC |
Bissell E. PerotDirector
|
GrantCommon Stock | 3,752 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-014575 · doc4.xml · nonDerivative · entry 1 Bissell E. Perot · CIK 0001420194 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,450 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 25, 2018. Read SEC document |
| May 25, 2017 Filed May 26, 2017 17:02 UTC |
Petrie William MDirector
|
GrantCommon Stock | 3,752 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-014572 · doc4.xml · nonDerivative · entry 1 Petrie William M · CIK 0001302671 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,239 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 25, 2018. Read SEC document |
| May 25, 2017 Filed May 26, 2017 21:01 UTC |
GRIECO WILLIAMDirector
|
GrantCommon Stock | 3,752 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-014571 · doc4.xml · nonDerivative · entry 1 GRIECO WILLIAM · CIK 0001248557 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,013 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 25, 2018. Read SEC document |
| May 25, 2017 Filed May 26, 2017 17:02 UTC |
Miquelon Wade DDirector
|
GrantCommon Stock | 3,752 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-014574 · doc4.xml · nonDerivative · entry 1 Miquelon Wade D · CIK 0001365176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,518 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 25, 2018. Read SEC document |
| May 25, 2017 Filed May 26, 2017 21:04 UTC |
Gregg Vicky BDirector
|
GrantCommon Stock | 3,752 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-014579 · doc4.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,592 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 25, 2018. Read SEC document |
| May 25, 2017 Filed May 26, 2017 21:02 UTC |
Rogers Hartley R.Director
|
GrantCommon Stock | 3,752 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-014573 · doc4.xml · nonDerivative · entry 1 Rogers Hartley R. · CIK 0001577084 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,450 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 25, 2018. Read SEC document |
| May 22, 2017 Filed Feb 7, 2018 18:03 UTC |
SHEAR BRUCE AExecutive Vice Chairman
|
Tax withholdingCommon Stock | 214 | $43.56 | $9,321.84 |
DisclosureSEC source: 0000899243-18-003119 · doc5.xml · nonDerivative · entry 6 SHEAR BRUCE A · CIK 0001243433 · Executive Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,129 Read SEC document |
| May 21, 2017 Filed Feb 7, 2018 18:03 UTC |
SHEAR BRUCE AExecutive Vice Chairman
|
Tax withholdingCommon Stock | 122 | $43.56 | $5,314.32 |
DisclosureSEC source: 0000899243-18-003119 · doc5.xml · nonDerivative · entry 5 SHEAR BRUCE A · CIK 0001243433 · Executive Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,343 Read SEC document |
| May 19, 2017 Filed Feb 7, 2018 18:03 UTC |
SHEAR BRUCE AExecutive Vice Chairman
|
Tax withholdingCommon Stock | 258 | $42.53 | $10,972.74 |
DisclosureSEC source: 0000899243-18-003119 · doc5.xml · nonDerivative · entry 4 SHEAR BRUCE A · CIK 0001243433 · Executive Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,465 Read SEC document |
| May 04, 2017 Filed May 5, 2017 21:01 UTC |
GOLDBERG RANDALL PVP of Business Development
|
Exercise / conversionStock Option · Derivative | 1,000 | $0.00 Strike: $29.39 | $0.00 |
DisclosureSEC source: 0000899243-17-012009 · doc4.xml · derivative · entry 3 GOLDBERG RANDALL P · CIK 0001533818 · VP of Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2023-03-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2017 Filed May 5, 2017 21:01 UTC |
GOLDBERG RANDALL PVP of Business Development
|
SaleCommon Stock | 4,925 | $45.18 | $222,511.50 |
DisclosureSEC source: 0000899243-17-012009 · doc4.xml · nonDerivative · entry 2 GOLDBERG RANDALL P · CIK 0001533818 · VP of Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,682 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.1650 to $45.2166, inclusive. The reporting person undertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 04, 2017 Filed May 5, 2017 21:01 UTC |
GOLDBERG RANDALL PVP of Business Development
|
Exercise / conversionCommon Stock | 1,000 | $29.39 | $29,390.00 |
DisclosureSEC source: 0000899243-17-012009 · doc4.xml · nonDerivative · entry 1 GOLDBERG RANDALL P · CIK 0001533818 · VP of Business Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2017 Filed May 3, 2017 17:13 UTC |
Fincher Ronald MorganChief Operating Officer
|
Exercise / conversionStock Option · Derivative | 13,350 | $0.00 Strike: $29.39 | $0.00 |
DisclosureSEC source: 0000899243-17-011670 · doc4.xml · derivative · entry 6 Fincher Ronald Morgan · CIK 0001448040 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,350 shares Expires 2023-03-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Options vested on March 29, 2016 and March 29, 2017. Read SEC document |
| May 02, 2017 Filed May 3, 2017 17:13 UTC |
Fincher Ronald MorganChief Operating Officer
|
Exercise / conversionStock Option · Derivative | 7,591 | $0.00 Strike: $15.96 | $0.00 |
DisclosureSEC source: 0000899243-17-011670 · doc4.xml · derivative · entry 5 Fincher Ronald Morgan · CIK 0001448040 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,591 shares Expires 2022-03-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.